The group at Brinkhof is well-placed to handle the remit of complex and high-value matters for its portfolio of well-known clients in both domestic and international contexts. It is noted that the team’s ‘desire to win is exceptional’. Its workload involves acting for clients in complex and high-stakes patent litigation work before both the UPC and the Dutch courts. Richard Ebbink handles disputes ranging from those regarding infringement and validity, to those involving patent enforcement; Mark van Gardingen is experienced acting for high-profile clients in the variety of disputes; and Daan de Lange has expertise in life sciences and FRAND-related litigation cases in particular. The three oversee the practice alongside Koen Bijvank who ’deserves all the accolades that he receives’, Jan Pot who has particular aptitude handling tech-related litigation, and Rien Broekstra who has experience acting before the UPC and the Dutch courts. Paul Marcelis is a key contact.
Legal 500 Editorial commentary
- Profile
Accolades
Client satisfaction
Testimonials
Collated independently by Legal 500 research team.
'A sounding board for us.’
‘Daan de Lange stands out for his thinking outside of the box.’
‘In a country where there is an abundance of great patent lawyers, Brinkhof stand out as excellent. Their desire to win is exceptional.'
'I would want them on my side every time.’
‘Mark van Gardingen is probably the leading patent lawyer in the Netherlands.'
'Daan de Lange is very strong.'
'Koen Bijvank deserves all the accolades that he receives.'
'Rik Lambers is good to work with.’
Key clients
- Accord Healthcare
- Agfa
- Alcon
- Alvotech
- Amgen
- Amycel
- Ballino
- Becton Dickinson
- Belmoca
- Boston Scientific
Work highlights
- Representing Amgen in several high-profile and internationally significant UPC and EPO proceedings against Sanofi and Regeneron regarding PCSK9 antibodies, a new type of medicine for lowering cholesterol in the blood based on monoclonal antibody technology.
- Representing OPPO in multi-jurisdictional patent disputes with a multitude of proprietors of standard essential patents, including Sisvel, Nokia, Panasonic and several others.
- Acting for the Broad Institute of MIT and Harvard in connection with its discovery and development of the ground-breaking CRISPR technology for genome editing, including representing our client in matters related to its significant European CRISPR patent portfolio and other patents.
Lawyers
Hall of fame
The lawyers at the very top of the profession, widely known and respected by peers and clients for their longstanding involvement in market-leading work.
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Next generation partners
Junior partners with significant recognition from clients and peers in the market and key roles on multiple matters.
Leading associates
Leading associates with regular involvement in their team's key work, and recognition from peers or clients as being ones to watch.
Paul Marcelis
Practice head
Richard Ebbink; Mark van Gardingen; Daan de Lange; Koen Bijvank; Jan Pot; Rien Broekstra
Other key lawyers
Rik Lambers; Paul Marcelis; Alexander de Leeuw; Barbara Mooij